FI925530L - Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk - Google Patents

Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk Download PDF

Info

Publication number
FI925530L
FI925530L FI925530A FI925530A FI925530L FI 925530 L FI925530 L FI 925530L FI 925530 A FI925530 A FI 925530A FI 925530 A FI925530 A FI 925530A FI 925530 L FI925530 L FI 925530L
Authority
FI
Finland
Prior art keywords
recombinantiskt
lipaser
framstaellda
terapeutiskt
bruk
Prior art date
Application number
FI925530A
Other languages
English (en)
Finnish (fi)
Other versions
FI925530A0 (fi
FI925530A7 (fi
Inventor
Birgitte Huge-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK137990A external-priority patent/DK137990D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI925530A0 publication Critical patent/FI925530A0/fi
Publication of FI925530A7 publication Critical patent/FI925530A7/fi
Publication of FI925530L publication Critical patent/FI925530L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
FI925530A 1990-06-06 1991-06-04 Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk FI925530L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK137990A DK137990D0 (da) 1990-06-06 1990-06-06 Rekombinante terapeutiske lipaser
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser
PCT/DK1991/000149 WO1991018623A1 (fr) 1990-06-06 1991-06-04 Lipases produites par procede recombinant et s'adressant au traitement therapeutique

Publications (3)

Publication Number Publication Date
FI925530A0 FI925530A0 (fi) 1992-12-04
FI925530A7 FI925530A7 (fi) 1992-12-04
FI925530L true FI925530L (fi) 1992-12-04

Family

ID=26065679

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925530A FI925530L (fi) 1990-06-06 1991-06-04 Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk

Country Status (10)

Country Link
US (1) US5614189A (fr)
EP (1) EP0600868B1 (fr)
JP (1) JP3072853B2 (fr)
AT (1) ATE178492T1 (fr)
AU (1) AU645583B2 (fr)
CA (1) CA2084184A1 (fr)
DE (1) DE69131106T2 (fr)
DK (1) DK173590D0 (fr)
FI (1) FI925530L (fr)
WO (1) WO1991018623A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
CA2560613C (fr) 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Compositions pharmaceutiques par voie orale a base de lipases, en particulier de pancreatine, contenant des tensioacitfs
DK1755656T3 (da) 2004-05-24 2010-10-04 Novozymes As Enzymer til farmaceutisk anvendelse
PT1809320E (pt) 2004-10-14 2010-10-25 Altus Pharmaceuticals Inc Composições contendo lipase, protease e amilase para o tratamento de insuficiência pancreática
NZ563777A (en) * 2005-06-24 2010-08-27 Novozymes As Serine protease derived from Bacillus licheniformis optionally in combination with lipases and amylases for pharmaceutical use
CN101208429A (zh) * 2005-06-24 2008-06-25 诺维信公司 用于药物用途的脂肪酶
AU2006261444A1 (en) 2005-06-24 2006-12-28 Novozymes A/S Amylases for pharmaceutical use
HUE031042T2 (en) 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
WO2007053619A2 (fr) 2005-11-01 2007-05-10 Bio-Cat, Inc. Composition contenant une lipase fongique (levure), et methode permettant de traiter la malabsorption lipidique liee a la mucoviscidose et l'insuffisance pancreatique chez des sujets concernes
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
KR20090101930A (ko) 2006-12-21 2009-09-29 노보자임스 에이/에스 약학적 사용을 위한 리파아제 변형체
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
US8455235B2 (en) * 2007-12-04 2013-06-04 Novozymes A/S Protease variants for pharmaceutical use
JP2011508755A (ja) * 2008-01-03 2011-03-17 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 精製微生物リパーゼの顆粒を有する医薬組成物ならびに消化器疾患を予防又は治療する方法
BRPI0922653B8 (pt) 2009-01-29 2021-05-25 Nordmark Arzneimittel Gmbh & Co Kg uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa
WO2011000924A1 (fr) 2009-07-03 2011-01-06 Abbott Products Gmbh Amylase séchée par pulvérisation, préparations pharmaceutiques la comprenant et son utilisation
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
WO2015019198A2 (fr) * 2013-07-22 2015-02-12 Aptalis Pharma S.R.L. Compositions pharmaceutiques de pancréatine de puissance élevée
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
WO2016126970A1 (fr) 2015-02-04 2016-08-11 Abbvie Inc. Compositions pharmaceutiques et méthodes d'utilisation de celles-ci pour traiter une insuffisance liée aux enzymes pancréatiques
DE102015114857A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421210D0 (en) * 1984-08-21 1984-09-26 Celltech Ltd Polypeptide and polypeptide composition
US4659667A (en) * 1985-02-26 1987-04-21 Miles Laboratories, Inc. Process to recover crystalline enzymes and crystalline enzymes produced thereby
US5108457A (en) * 1986-11-19 1992-04-28 The Clorox Company Enzymatic peracid bleaching system with modified enzyme
EP0305216B1 (fr) * 1987-08-28 1995-08-02 Novo Nordisk A/S Lipase recombinante de humicola et procédé de production de lipases recombinantes de humicola
WO1991009941A1 (fr) * 1989-12-21 1991-07-11 Novo Nordisk A/S Preparation contenant des enzymes et detergent contenant une telle preparation

Also Published As

Publication number Publication date
JP3072853B2 (ja) 2000-08-07
JPH06501147A (ja) 1994-02-10
US5614189A (en) 1997-03-25
DK173590D0 (da) 1990-07-19
AU8096491A (en) 1991-12-31
DE69131106D1 (de) 1999-05-12
EP0600868A1 (fr) 1994-06-15
DE69131106T2 (de) 1999-11-18
WO1991018623A1 (fr) 1991-12-12
AU645583B2 (en) 1994-01-20
EP0600868B1 (fr) 1999-04-07
FI925530A0 (fi) 1992-12-04
FI925530A7 (fi) 1992-12-04
ATE178492T1 (de) 1999-04-15
CA2084184A1 (fr) 1991-12-07

Similar Documents

Publication Publication Date Title
FI925530L (fi) Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk
FI932069A0 (fi) Injektionsspruta
FI930433L (fi) Bitminnescell
FI930077A0 (fi) Oxamider
FI925030L (fi) Iontoforetisk administreringsanordning
FI932690A0 (fi) Tereftalsyras kopolyamider
FI931366L (fi) Foerbaettrade schampokompositioner
FI931976A0 (fi) Samlat koncentriskt tangentialbraennsystem
FI931369A0 (fi) Flytande detergentkompositioner
FI931514L (fi) Rengoeringsanordning foer roerledningar
FI930058L (fi) O-glykolyserad alfa-ifn
FI934577L (fi) Skyddshylsa foer envaegsventil
FI932324L (fi) Gelbildande flytande naeringsfibersammansaettning
FI931225A0 (fi) Milda shampokompositioner
FI931457L (fi) Aprotininanaloger
FI932833A0 (fi) Koppling foer flaensroer
FI915674A0 (fi) Kalliopultituslaite
DE59107143D1 (de) N-Heteroaryl-2-nitroaniline
ITMI911945A0 (it) Liccio
FI932197A0 (fi) Semduramicinfoerblandning
FI931157A0 (fi) 5-trifluoracylamino-2-aryloxatzoler
FI925356A0 (fi) Fastspaenningslock foer rullningshylsor
FI931702A0 (fi) Indenoindolefoereningar
FI925611A0 (fi) Heterocykliska antracyklidon- och antracyklinanaloger
ATA80690A (de) Alpinschi

Legal Events

Date Code Title Description
FD Application lapsed